Showing results (2771-2780 of 2,819) with videos related to
Sort By:
Pageof 282
Nature Ecology & Evolution|May 1, 2023
Phenological shifts and mismatch with marine productivity vary among Pacific salmon species and populationsSamantha M Wilson, Jonathan W Moore, Eric J Ward, et al.JAMA Network Open|February 17, 2026
Chronic Kidney Disease Severity and Risk of Cognitive ImpairmentZhijie Huang, Kristine Yaffe, Changwei Li, et al.American Journal of Respiratory Cell and Molecular Biology|November 2, 2010
Genome-wide association analysis of body mass in chronic obstructive pulmonary diseaseEmily S Wan, Michael H Cho, Nadia Boutaoui, et al.British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: TransportersStephen Ph Alexander, Eamonn Kelly, Alistair Mathie, et al.Chest|November 21, 2021
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPDCharles R Esther, Wanda K O'Neal, Wayne H Anderson, et al.European Journal of Human Genetics : EJHG|January 5, 2006
A genome-wide search for linkage to asthma phenotypes in the genetics of asthma international network families: evidence for a major susceptibility locus on chromosome 2pSreekumar G Pillai, Mathias N Chiano, Nicola J White, et al.Plos One|September 22, 2017
Variability in objective and subjective measures affects baseline values in studies of patients with COPDWayne H Anderson, Jae Wook Ha, David J Couper, et al.Neuropharmacology|September 28, 2013
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disordersLinda M Rorick-Kehn, Jeffrey M Witkin, Michael A Statnick, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ DamagePaul E Drawz, Arnold B Alper, Amanda H Anderson, et al.Chest|November 7, 2022
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD CohortW Blake LeMaster, P Miguel Quibrera, David Couper, et al.Pageof 282